Rachel McMahan
Concepts (299)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 13 | 2026 | 376 | 3.350 |
Why?
| | Ethanol | 11 | 2026 | 625 | 1.940 |
Why?
| | Gastrointestinal Microbiome | 7 | 2026 | 771 | 1.900 |
Why?
| | Alcoholic Intoxication | 3 | 2025 | 74 | 1.210 |
Why?
| | Pancreatitis-Associated Proteins | 2 | 2025 | 12 | 1.120 |
Why?
| | Dysbiosis | 5 | 2025 | 187 | 1.110 |
Why?
| | Pneumonia | 4 | 2025 | 630 | 0.910 |
Why?
| | Inflammation | 10 | 2025 | 2877 | 0.900 |
Why?
| | Feces | 3 | 2025 | 513 | 0.890 |
Why?
| | Blood-Brain Barrier | 1 | 2026 | 155 | 0.870 |
Why?
| | Intestines | 3 | 2022 | 358 | 0.830 |
Why?
| | Alcohol Drinking | 5 | 2025 | 812 | 0.810 |
Why?
| | Public Opinion | 2 | 2023 | 60 | 0.800 |
Why?
| | Liver | 9 | 2025 | 1884 | 0.760 |
Why?
| | Mice, Inbred C57BL | 19 | 2026 | 5988 | 0.700 |
Why?
| | Mice | 32 | 2026 | 18329 | 0.610 |
Why?
| | Receptors, Antigen, T-Cell | 6 | 2017 | 668 | 0.580 |
Why?
| | Hepacivirus | 5 | 2017 | 243 | 0.570 |
Why?
| | Non-alcoholic Fatty Liver Disease | 5 | 2020 | 265 | 0.540 |
Why?
| | Prenatal Exposure Delayed Effects | 2 | 2024 | 674 | 0.510 |
Why?
| | Animals | 37 | 2026 | 38030 | 0.480 |
Why?
| | Alcoholism | 5 | 2024 | 808 | 0.470 |
Why?
| | Intestinal Mucosa | 5 | 2025 | 676 | 0.460 |
Why?
| | Bacterial Translocation | 2 | 2026 | 52 | 0.460 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2016 | 209 | 0.450 |
Why?
| | Disease Models, Animal | 13 | 2025 | 4556 | 0.440 |
Why?
| | T-Lymphocytes | 7 | 2017 | 1982 | 0.420 |
Why?
| | Fatty Liver | 2 | 2013 | 251 | 0.400 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2025 | 233 | 0.380 |
Why?
| | T-Lymphocytes, Cytotoxic | 2 | 2010 | 177 | 0.370 |
Why?
| | Hepatitis C, Chronic | 2 | 2011 | 152 | 0.360 |
Why?
| | Macrophages | 8 | 2024 | 1510 | 0.360 |
Why?
| | Cancer Vaccines | 3 | 2010 | 160 | 0.350 |
Why?
| | Epitopes, T-Lymphocyte | 2 | 2016 | 175 | 0.350 |
Why?
| | Monocytes | 3 | 2013 | 538 | 0.350 |
Why?
| | Liver Diseases | 2 | 2025 | 304 | 0.320 |
Why?
| | Aging | 6 | 2025 | 1964 | 0.320 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2010 | 186 | 0.310 |
Why?
| | Age Factors | 4 | 2025 | 3313 | 0.290 |
Why?
| | Cytokines | 5 | 2025 | 2061 | 0.290 |
Why?
| | Major Histocompatibility Complex | 3 | 2017 | 229 | 0.280 |
Why?
| | Lymphocyte Activation | 4 | 2007 | 1126 | 0.270 |
Why?
| | Permeability | 3 | 2022 | 168 | 0.260 |
Why?
| | Glycerophospholipids | 2 | 2025 | 36 | 0.260 |
Why?
| | Antigens, CD | 1 | 2010 | 555 | 0.260 |
Why?
| | Macrophages, Alveolar | 3 | 2022 | 368 | 0.260 |
Why?
| | Male | 24 | 2026 | 72035 | 0.250 |
Why?
| | Tryptophan | 2 | 2025 | 180 | 0.240 |
Why?
| | Myelin Basic Protein | 2 | 2003 | 44 | 0.240 |
Why?
| | Histocompatibility Antigens Class II | 2 | 2024 | 364 | 0.240 |
Why?
| | Colon | 2 | 2025 | 304 | 0.230 |
Why?
| | Calgranulin A | 1 | 2025 | 11 | 0.230 |
Why?
| | Laparotomy | 1 | 2025 | 112 | 0.230 |
Why?
| | Biomarkers | 4 | 2025 | 4254 | 0.220 |
Why?
| | Membrane Proteins | 2 | 2013 | 1165 | 0.220 |
Why?
| | Kupffer Cells | 2 | 2019 | 53 | 0.220 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2025 | 86 | 0.220 |
Why?
| | Immunity, Innate | 2 | 2024 | 846 | 0.220 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2025 | 79 | 0.220 |
Why?
| | tau Proteins | 1 | 2025 | 114 | 0.210 |
Why?
| | Immunity | 1 | 2025 | 139 | 0.210 |
Why?
| | Azepines | 1 | 2024 | 107 | 0.210 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2024 | 60 | 0.200 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2024 | 137 | 0.200 |
Why?
| | Graft Rejection | 1 | 2007 | 540 | 0.200 |
Why?
| | Diet, Western | 1 | 2024 | 86 | 0.200 |
Why?
| | Microglia | 1 | 2026 | 268 | 0.200 |
Why?
| | Triazoles | 1 | 2024 | 184 | 0.200 |
Why?
| | Cellular Senescence | 1 | 2025 | 226 | 0.200 |
Why?
| | Central Nervous System | 1 | 2025 | 281 | 0.190 |
Why?
| | Binge Drinking | 1 | 2023 | 44 | 0.190 |
Why?
| | Hawaii | 1 | 2023 | 46 | 0.190 |
Why?
| | Postoperative Complications | 2 | 2025 | 2916 | 0.190 |
Why?
| | Respiratory Function Tests | 1 | 2025 | 546 | 0.190 |
Why?
| | alpha-Defensins | 1 | 2022 | 11 | 0.190 |
Why?
| | Lung | 6 | 2025 | 4108 | 0.190 |
Why?
| | Cell Proliferation | 2 | 2025 | 2494 | 0.180 |
Why?
| | Cytotoxicity, Immunologic | 4 | 2013 | 223 | 0.180 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 47 | 0.180 |
Why?
| | Galectins | 2 | 2013 | 27 | 0.170 |
Why?
| | Delirium | 1 | 2023 | 104 | 0.170 |
Why?
| | Tight Junctions | 1 | 2021 | 81 | 0.170 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 103 | 0.170 |
Why?
| | Cell Cycle Proteins | 1 | 2024 | 628 | 0.160 |
Why?
| | Astrocytes | 1 | 2022 | 222 | 0.160 |
Why?
| | Hepatitis C | 2 | 2016 | 254 | 0.160 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 114 | 0.160 |
Why?
| | Diet, High-Fat | 3 | 2020 | 261 | 0.160 |
Why?
| | Boston | 1 | 2020 | 92 | 0.160 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 63 | 0.150 |
Why?
| | Humans | 28 | 2025 | 144261 | 0.150 |
Why?
| | Glomerulonephritis | 2 | 2018 | 45 | 0.150 |
Why?
| | Nuclear Proteins | 1 | 2024 | 748 | 0.150 |
Why?
| | Myocardium | 1 | 2024 | 939 | 0.150 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 15 | 0.150 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 10 | 0.150 |
Why?
| | Perilipin-2 | 1 | 2019 | 40 | 0.140 |
Why?
| | Congresses as Topic | 1 | 2020 | 221 | 0.140 |
Why?
| | Osteopontin | 1 | 2018 | 34 | 0.140 |
Why?
| | Gastrointestinal Tract | 1 | 2020 | 208 | 0.130 |
Why?
| | Hepatocytes | 1 | 2019 | 221 | 0.130 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1217 | 0.130 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 128 | 0.130 |
Why?
| | Interleukin-10 | 2 | 2024 | 309 | 0.130 |
Why?
| | Antigens, Neoplasm | 2 | 2010 | 271 | 0.130 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1208 | 0.130 |
Why?
| | Sevelamer | 1 | 2016 | 9 | 0.120 |
Why?
| | Histocompatibility Antigens Class I | 2 | 2016 | 202 | 0.120 |
Why?
| | Transcription Factors | 1 | 2024 | 1739 | 0.120 |
Why?
| | Receptor, Adenosine A2A | 1 | 2016 | 23 | 0.120 |
Why?
| | Adenosine A2 Receptor Agonists | 1 | 2016 | 24 | 0.120 |
Why?
| | Immunotherapy | 3 | 2017 | 652 | 0.120 |
Why?
| | Mice, Inbred BALB C | 4 | 2010 | 1253 | 0.120 |
Why?
| | Genomic Instability | 1 | 2016 | 66 | 0.110 |
Why?
| | Microbiota | 1 | 2023 | 781 | 0.110 |
Why?
| | Neoplasms | 2 | 2008 | 2870 | 0.110 |
Why?
| | Female | 14 | 2025 | 77976 | 0.110 |
Why?
| | Hepatitis A Virus Cellular Receptor 2 | 2 | 2013 | 29 | 0.110 |
Why?
| | Ligands | 3 | 2023 | 673 | 0.100 |
Why?
| | Fructokinases | 1 | 2013 | 41 | 0.100 |
Why?
| | Brain | 1 | 2026 | 2930 | 0.100 |
Why?
| | Aspartate Aminotransferases | 2 | 2025 | 85 | 0.100 |
Why?
| | Pregnancy | 2 | 2024 | 7180 | 0.100 |
Why?
| | Mannose-Binding Lectins | 1 | 2013 | 10 | 0.100 |
Why?
| | Sucrose | 1 | 2013 | 112 | 0.100 |
Why?
| | Mice, Obese | 1 | 2013 | 66 | 0.100 |
Why?
| | Alanine Transaminase | 2 | 2025 | 151 | 0.100 |
Why?
| | Mice, Knockout | 5 | 2024 | 3119 | 0.100 |
Why?
| | Lectins, C-Type | 1 | 2013 | 62 | 0.100 |
Why?
| | Antibodies, Blocking | 2 | 2010 | 37 | 0.100 |
Why?
| | Interleukin-6 | 3 | 2025 | 780 | 0.090 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 474 | 0.090 |
Why?
| | Cyclic AMP | 1 | 2013 | 208 | 0.090 |
Why?
| | Chemokines | 2 | 2023 | 218 | 0.090 |
Why?
| | Macrophage Activation | 1 | 2013 | 193 | 0.090 |
Why?
| | Herpesviridae Infections | 1 | 2013 | 150 | 0.090 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 381 | 0.080 |
Why?
| | Receptors, Cell Surface | 1 | 2013 | 377 | 0.080 |
Why?
| | Conserved Sequence | 1 | 2011 | 245 | 0.080 |
Why?
| | Peptide Library | 2 | 2010 | 95 | 0.080 |
Why?
| | Vaccines, Subunit | 1 | 2010 | 53 | 0.080 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2010 | 94 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2013 | 467 | 0.080 |
Why?
| | Genome, Viral | 1 | 2011 | 218 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1047 | 0.070 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2010 | 264 | 0.070 |
Why?
| | Viral Proteins | 1 | 2011 | 355 | 0.070 |
Why?
| | T-Lymphocyte Subsets | 1 | 2010 | 415 | 0.070 |
Why?
| | Ischemia | 1 | 2011 | 421 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 2017 | 2154 | 0.070 |
Why?
| | Kidney | 2 | 2016 | 1495 | 0.070 |
Why?
| | Baculoviridae | 1 | 2008 | 44 | 0.070 |
Why?
| | Cloning, Molecular | 3 | 2004 | 539 | 0.070 |
Why?
| | H-2 Antigens | 1 | 2008 | 111 | 0.070 |
Why?
| | Up-Regulation | 1 | 2010 | 851 | 0.070 |
Why?
| | Insecta | 1 | 2008 | 74 | 0.070 |
Why?
| | Cross Reactions | 2 | 2017 | 130 | 0.060 |
Why?
| | Rats, Inbred Lew | 2 | 2003 | 103 | 0.060 |
Why?
| | Keratin-18 | 1 | 2025 | 12 | 0.060 |
Why?
| | Genetic Variation | 1 | 2011 | 982 | 0.060 |
Why?
| | Young Adult | 3 | 2025 | 13990 | 0.060 |
Why?
| | Cathelicidins | 1 | 2025 | 41 | 0.060 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2025 | 73 | 0.060 |
Why?
| | Aged | 4 | 2025 | 25850 | 0.060 |
Why?
| | Chemokine CXCL1 | 1 | 2025 | 76 | 0.060 |
Why?
| | Immune Tolerance | 1 | 2008 | 379 | 0.060 |
Why?
| | Colonic Neoplasms | 1 | 2008 | 259 | 0.060 |
Why?
| | Cholera Toxin | 1 | 2025 | 29 | 0.060 |
Why?
| | Drug Design | 1 | 2006 | 173 | 0.060 |
Why?
| | DNA Primers | 1 | 2006 | 511 | 0.060 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2025 | 68 | 0.060 |
Why?
| | Obesity | 1 | 2019 | 3057 | 0.060 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2025 | 123 | 0.060 |
Why?
| | Neurofilament Proteins | 1 | 2025 | 77 | 0.060 |
Why?
| | Kynurenine | 1 | 2025 | 113 | 0.060 |
Why?
| | Bacteroidetes | 1 | 2024 | 21 | 0.050 |
Why?
| | Haptoglobins | 1 | 2025 | 66 | 0.050 |
Why?
| | Fecal Microbiota Transplantation | 1 | 2024 | 26 | 0.050 |
Why?
| | Protein Precursors | 1 | 2025 | 136 | 0.050 |
Why?
| | Adult | 5 | 2025 | 40262 | 0.050 |
Why?
| | Receptors, Interleukin-2 | 1 | 2004 | 64 | 0.050 |
Why?
| | Signal Transduction | 3 | 2024 | 5221 | 0.050 |
Why?
| | Ileum | 1 | 2024 | 111 | 0.050 |
Why?
| | Fatty Acids, Volatile | 1 | 2024 | 60 | 0.050 |
Why?
| | Middle Aged | 4 | 2025 | 35762 | 0.050 |
Why?
| | Acute Kidney Injury | 1 | 2011 | 862 | 0.050 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2603 | 0.050 |
Why?
| | Recombinant Proteins | 2 | 2004 | 1367 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2010 | 3592 | 0.050 |
Why?
| | Solubility | 1 | 2003 | 242 | 0.050 |
Why?
| | Body Surface Area | 1 | 2022 | 35 | 0.050 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2024 | 181 | 0.050 |
Why?
| | Burn Units | 1 | 2022 | 48 | 0.050 |
Why?
| | Cells, Cultured | 2 | 2024 | 4146 | 0.050 |
Why?
| | Occludin | 1 | 2021 | 11 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2010 | 1128 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2010 | 844 | 0.040 |
Why?
| | Fibroblasts | 2 | 2024 | 1032 | 0.040 |
Why?
| | Liver Cirrhosis | 1 | 2023 | 288 | 0.040 |
Why?
| | Molecular Sequence Data | 2 | 2003 | 2929 | 0.040 |
Why?
| | Malondialdehyde | 1 | 2021 | 30 | 0.040 |
Why?
| | Autoimmunity | 1 | 2007 | 924 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 661 | 0.040 |
Why?
| | Cell Line | 3 | 2017 | 2879 | 0.040 |
Why?
| | Protein Structure, Tertiary | 1 | 2003 | 862 | 0.040 |
Why?
| | Intercellular Junctions | 1 | 2020 | 35 | 0.040 |
Why?
| | Lipid Peroxidation | 1 | 2021 | 160 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 27 | 0.040 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2001 | 66 | 0.040 |
Why?
| | Mice, Transgenic | 3 | 2011 | 2182 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 177 | 0.040 |
Why?
| | Histocompatibility Antigens | 1 | 2001 | 102 | 0.040 |
Why?
| | Epitopes | 2 | 2017 | 485 | 0.040 |
Why?
| | Organ Specificity | 1 | 2020 | 312 | 0.040 |
Why?
| | Interferon-gamma | 3 | 2010 | 784 | 0.040 |
Why?
| | Antigen Presentation | 1 | 2001 | 205 | 0.040 |
Why?
| | MicroRNAs | 1 | 2025 | 700 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2023 | 1533 | 0.040 |
Why?
| | Glutathione | 1 | 2021 | 375 | 0.040 |
Why?
| | Hepatitis | 1 | 2019 | 43 | 0.040 |
Why?
| | Escherichia coli | 1 | 2003 | 852 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2020 | 321 | 0.030 |
Why?
| | Gene Expression | 1 | 2003 | 1487 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2010 | 8243 | 0.030 |
Why?
| | Urinary Tract | 1 | 2018 | 48 | 0.030 |
Why?
| | Isoantigens | 1 | 2017 | 17 | 0.030 |
Why?
| | Nucleoside-Triphosphatase | 1 | 2017 | 14 | 0.030 |
Why?
| | HLA-A2 Antigen | 1 | 2017 | 35 | 0.030 |
Why?
| | Molecular Mimicry | 1 | 2017 | 37 | 0.030 |
Why?
| | Peptides | 2 | 2017 | 995 | 0.030 |
Why?
| | Jurkat Cells | 1 | 2017 | 114 | 0.030 |
Why?
| | Rats | 2 | 2003 | 5592 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2022 | 684 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 356 | 0.030 |
Why?
| | Apoptosis | 1 | 2025 | 2430 | 0.030 |
Why?
| | Viral Nonstructural Proteins | 1 | 2017 | 67 | 0.030 |
Why?
| | Glomerular Basement Membrane | 1 | 2016 | 8 | 0.030 |
Why?
| | Hippocampus | 1 | 2022 | 965 | 0.030 |
Why?
| | Bacteria | 1 | 2023 | 889 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 523 | 0.030 |
Why?
| | DEAD-box RNA Helicases | 1 | 2017 | 90 | 0.030 |
Why?
| | Homeostasis | 1 | 2020 | 640 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 2017 | 128 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3157 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1134 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 2 | 2016 | 917 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1519 | 0.030 |
Why?
| | Crystallography, X-Ray | 1 | 2017 | 492 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 313 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2019 | 525 | 0.030 |
Why?
| | Antigens, Viral | 1 | 2016 | 182 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2017 | 744 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1258 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2023 | 17009 | 0.030 |
Why?
| | Adipose Tissue | 1 | 2019 | 651 | 0.030 |
Why?
| | Glucose | 1 | 2019 | 1046 | 0.020 |
Why?
| | Muromegalovirus | 1 | 2013 | 23 | 0.020 |
Why?
| | Fructose | 1 | 2013 | 129 | 0.020 |
Why?
| | Receptors, Virus | 1 | 2013 | 96 | 0.020 |
Why?
| | Interleukin-15 | 1 | 2013 | 97 | 0.020 |
Why?
| | Interleukin-12 | 1 | 2013 | 117 | 0.020 |
Why?
| | Transcriptome | 1 | 2019 | 1044 | 0.020 |
Why?
| | Models, Molecular | 1 | 2017 | 1618 | 0.020 |
Why?
| | Genes, Viral | 1 | 2011 | 90 | 0.020 |
Why?
| | Entropy | 1 | 2011 | 45 | 0.020 |
Why?
| | Disease Progression | 1 | 2019 | 2840 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10699 | 0.020 |
Why?
| | Energy Intake | 1 | 2013 | 499 | 0.020 |
Why?
| | Nucleotides | 1 | 2011 | 128 | 0.020 |
Why?
| | Interleukin-7 Receptor alpha Subunit | 1 | 2010 | 11 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2019 | 1232 | 0.020 |
Why?
| | Vaccination | 2 | 2010 | 1422 | 0.020 |
Why?
| | Spodoptera | 1 | 2010 | 40 | 0.020 |
Why?
| | Immunodominant Epitopes | 1 | 2010 | 27 | 0.020 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 80 | 0.020 |
Why?
| | Weight Gain | 1 | 2013 | 556 | 0.020 |
Why?
| | CD4 Antigens | 1 | 2010 | 139 | 0.020 |
Why?
| | Forkhead Transcription Factors | 1 | 2010 | 202 | 0.020 |
Why?
| | Histocompatibility Antigen H-2D | 1 | 2008 | 20 | 0.020 |
Why?
| | Cross-Priming | 1 | 2008 | 16 | 0.020 |
Why?
| | CD11c Antigen | 1 | 2008 | 40 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2187 | 0.020 |
Why?
| | Leukocytes, Mononuclear | 1 | 2010 | 573 | 0.020 |
Why?
| | RNA, Viral | 1 | 2011 | 687 | 0.020 |
Why?
| | Amino Acids | 1 | 2011 | 521 | 0.020 |
Why?
| | Chronic Disease | 1 | 2011 | 1812 | 0.010 |
Why?
| | Silver Staining | 1 | 2004 | 16 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2008 | 499 | 0.010 |
Why?
| | Genes, MHC Class II | 1 | 2004 | 76 | 0.010 |
Why?
| | Coculture Techniques | 1 | 2004 | 246 | 0.010 |
Why?
| | Cell Lineage | 1 | 2004 | 376 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 981 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 850 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3539 | 0.010 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2001 | 138 | 0.010 |
Why?
| | Flow Cytometry | 1 | 2004 | 1172 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 7155 | 0.010 |
Why?
| | Transfection | 1 | 2001 | 938 | 0.010 |
Why?
| | Adolescent | 1 | 2011 | 22281 | 0.010 |
Why?
|
|
McMahan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|